Lung Fung Group Holdings Limited (2290.HK)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in HKDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HKD m | - | - | - | - | - | - | - | - |
| Operating profit | HKD m | - | |||||||
| Net profit | HKD m | - | - | - | - | - | - | - | - |
| EPS reported | HKD | - | |||||||
| Operating cashflow per share | HKD | - | |||||||
| Capex per share | HKD | - | |||||||
| FCF per share | HKD | - | |||||||
| Free cash flow | HKD m | - | |||||||
| Net debt | HKD m | - | |||||||
| Book value equity | HKD m | - | |||||||
| Book value per share | HKD | - | |||||||
| Number of shares | m | - | |||||||
| DPS (TTM paid) | HKD | - |
Financial summary
Financials in HKDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | |||||||
| P/B LTM | x | - | |||||||
| P/S LTM | x | - | |||||||
| P/FCF LTM | x | - | |||||||
| EV/EBITDA LTM | x | - | |||||||
| EV/Sales LTM | x | - | |||||||
| Earnings Yield LTM | % | - | |||||||
| FCF Yield | % | - | |||||||
| Quality | |||||||||
| ROE | % | - | |||||||
| ROIC | % | - | |||||||
| Operating margin | % | - | |||||||
| Gross margin | % | - | |||||||
| FCF/Sales | % | - | |||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | |||||||
| Sales Growth YoY | % | - | |||||||
| Net Income Growth YoY | % | - | |||||||
| FCF Growth | % | - | |||||||
| Operating Profit Growth | % | - | |||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | - | |||||||
| Dividend Growth | % | - | |||||||
| Payout Ratio | % | - | |||||||
| FCF/Debt | x | - | |||||||
| Net Debt/EBITDA | x | - | |||||||
| EBIT/Net interest | x | - | |||||||
| Net debt/market cap | % | - | |||||||
| Net debt/Equity | x | - | |||||||
| Gross debt/equity | x | - | |||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. It offers Chinese and western medicines, health supplements, medical supplies, beauty and skincare products, cosmetics, baby and maternity products, food, fragrances, personal care, and pet food and household daily necessities goods. The company sells its products through retail stores and online sale platforms. The company was founded in 1992 and is headquartered in Fanling, New Territories, Hong Kong. Lung Fung Group Holdings Limited operates as a subsidiary of TTK Holding Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Lung Fung Group Holdings Limited (2290.HK)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. It offers Chinese and western medicines, health supplements, medical supplies, beauty and skincare products, cosmetics, baby and maternity products, food, fragrances, personal care, and pet food and household daily necessities goods. The company sells its products through retail stores and online sale platforms. The company was founded in 1992 and is headquartered in Fanling, New Territories, Hong Kong. Lung Fung Group Holdings Limited operates as a subsidiary of TTK Holding Limited.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free